Vascular Tickers $ANGO, $AORT, $LMAT, $AKBA, and $AVGR Surge +252.11% in a Single Day
The Vascular group of tickers has recently made waves by recording a staggering +252.11% increase in performance over just one day. This remarkable surge has garnered significant attention from investors and traders alike, prompting a closer examination of the theme and the individual tickers within it.
Vascular Tickers in Focus: $ANGO, $AORT, $LMAT, $AKBA and $AVGR
The Vascular theme is represented by a group of five tickers: ANGO, AORT, LMAT, AKBA, and AVGR. These companies operate in the vascular industry, which encompasses a wide range of medical and healthcare-related activities. While this theme has recently experienced a surge in performance, it's essential to consider both short-term and long-term factors when evaluating investment opportunities within this sector.
Negative Outlook with Bearish Predictions
Despite the recent surge, Tickeron, a prominent market prediction source, has a negative outlook on this group of vascular tickers. Tickeron predicts a potential decline of more than 4.00% within the next month, with a likelihood of 61%. This bearish forecast suggests that investors should exercise caution and conduct thorough research before considering investments in these stocks.
Volume Trends and Market Sentiment
Analyzing volume trends can provide valuable insights into market sentiment. Over the last month, the daily ratio of advancing to declining volumes in the vascular theme was 1 to 1.18. This indicates that there has been a balance between buying and selling activity within this sector, contributing to the recent price surge.
Market Capitalization Diversity
The market capitalization of companies within the vascular theme varies significantly. On average, these companies have a market capitalization of approximately $490.6 million. Among the five tickers in focus, LMAT holds the highest valuation, with a market capitalization of $1.3 billion. In contrast, AVGR is the lowest valued company in this group, with a market capitalization of only $4.6 million. This wide range of market caps within the theme highlights the diversity of investment opportunities available in the vascular sector.
Price Performance and Notable News
The price performance of vascular-related stocks has been nothing short of spectacular in the short term. On a weekly basis, the average price growth across all stocks in this theme was an astonishing 200.28%, indicating rapid gains. The average monthly and quarterly price growth figures were equally impressive, standing at 140.05% and 107.46%, respectively. However, it's important to note that these figures represent short-term volatility.
Individual Ticker Analysis
Let's take a closer look at three of the key tickers within this theme:
-
ANGO: The Aroon Indicator for ANGO entered a downward trend on August 18, 2023. This bearish signal, combined with historical patterns, suggests a potential downward move. Traders may consider selling the stock or buying put options. While ANGO has experienced recent challenges, the stock fell by just 1% during the week of 09/05/23 - 09/12/23.
-
AORT: AORT saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on September 05, 2023. This bearish signal indicates a possible decline ahead. Historical data shows that in 84% of similar instances, the stock moved lower after such a signal. While AORT experienced a recent -1% decline during the week of 09/05/23 - 09/12/23, it's important to monitor its performance closely.
-
LMAT: LMAT's MACD Histogram turned positive on August 23, 2023, signaling a potential upward trend. Historical data suggests that in 78% of similar instances, the stock continued to rise over the following month. LMAT has enjoyed a +3% uptrend during the week of 09/05/23 - 09/12/23, and its current price is above the highest support line found by A.I.
In summary, the recent surge in performance within the Vascular theme has been exceptional, but it's crucial for investors to approach this sector with caution due to the negative outlook and bearish predictions. While there are opportunities for short-term gains, the long-term stability of these stocks should be carefully considered. As with any investment, thorough research and risk assessment are essential before making decisions in the ever-changing world of financial markets.
Momentum Indicator for AVGR turns negative, indicating new downward trend
AVGR saw its Momentum Indicator move below the 0 level on December 11, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In of the 76 cases, the stock moved further down in the following days. The odds of a decline are at .
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for AVGR turned negative on December 12, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVGR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for AVGR entered a downward trend on December 20, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AVGR's RSI Indicator exited the oversold zone, of 53 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where AVGR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AVGR advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .
AVGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.018) is normal, around the industry mean (23.300). P/E Ratio (0.000) is within average values for comparable stocks, (83.485). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.307) is also within normal values, averaging (43.338).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AVGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
a manufacturer of catheter devices used to treat vascular diseases
Industry MedicalSpecialties